JJ.jj wrote:
Legislation has been proposed that would allow herbal treatment manufacturers to use in their advertisements customers’ claims that this treatment effectively combat certain diseases. Such advertisements would be permitted only for products that have long been in common use with no record of harm, even when used in high doses. The proposal’s backers reason that this criterion should ensure that such advertisement do no harm even if they lead people to take ineffective treatments, for if the products are safe when taken regularly in large doses, they should remain safe at smaller or equal doses.
Which of the following would, if true, most undermine the reasoning of the proposal’s backers?
A Most people who believe that herbal treatments are medicinally efficacious base their belief on rumors and folklore.
B The active ingredients in many orthodox medicines are extracted from herbs.
C If people are told that herbal treatments have health benefits, they may buy greater quantities of them.
D Most people who are taking a particular treatment for health problem generally will not at the same time try other treatments that may be more effective.
E If herbal treatments are widely believed to have benefits, then the prices of these products will increase.
The reasoning of the proposal’s backers hinges on the assumption that allowing herbal treatment manufacturers to advertise customer claims about the effectiveness of their products, based on safety at high doses, would not lead to harm even if the treatments are ineffective. To undermine this reasoning, we need to identify an option that suggests a scenario where harm could still occur, despite the safety of the treatments at high doses.
Let's evaluate the options:
A) Most people who believe that herbal treatments are medicinally efficacious base their belief on rumors and folklore.- This option does not directly undermine the safety or harmlessness aspect of the reasoning. It addresses why people might believe in the efficacy of herbal treatments, but does not suggest that allowing such advertisements would lead to harm.
B) The active ingredients in many orthodox medicines are extracted from herbs.- While interesting, this fact does not undermine the proposal’s backers' reasoning. It might even support the notion that herbs have medicinal value, but it doesn’t address the potential for harm from advertisements about herbal treatments.
C) If people are told that herbal treatments have health benefits, they may buy greater quantities of them.- This option begins to approach an undermining argument by suggesting that increased consumption could follow from the advertisements. However, to fully undermine the backers' reasoning, we'd need to connect increased consumption directly to potential harm, which this option stops short of doing explicitly. Nonetheless, it implies that increased consumption beyond what is tested (safe at high doses) might not be safe, suggesting a scenario where harm could occur.
D) Most people who are taking a particular treatment for a health problem generally will not at the same time try other treatments that may be more effective.- This option directly undermines the reasoning by highlighting a specific harm that could result from the advertisements: If people believe in the efficacy of herbal treatments based on these ads, they might forego other, more effective treatments. This could lead to harm not through the physical effects of the herbs themselves but through the opportunity cost of not pursuing better medical solutions.E) If herbal treatments are widely believed to have benefits, then the prices of these products will increase.- While this could be seen as a negative consequence (higher prices), it does not directly address the harm that could come from the treatments' effectiveness or safety, which is the core concern of the proposal’s backers.
Option D most directly undermines the reasoning by illustrating a scenario where allowing these advertisements could lead to harm, not because of the physical safety of the herbal treatments, but because it might prevent people from seeking more effective treatments. This scenario challenges the assumption that no harm would come from the advertisements on the basis that the treatments are safe at any dose.